I write about GLP-1s, peptides and new molecules with one rule: start from the evidence, then look at what social media turned them into.
Some molecules have a real place. Others live mostly on anecdotes, shortcuts, and promises.
Join 1,000+ readers.
Mechanisms, use cases, limits, weak signals: GLP-1s, peptides, genome, sleep. Everything published so far, newest first.